Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.

Guex JJ, Enriquez Vega DM, Avril L, Boussetta S, Taïeb C.

Phlebology. 2009 Aug;24(4):157-65. doi: 10.1258/phleb.2009.008066.

PMID:
19620698
4.

The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of chronic venous disease.

Jawien A, Bouskela E, Allaert FA, Nicolaïdes AN.

Int Angiol. 2017 Feb;36(1):31-41. doi: 10.23736/S0392-9590.16.03788-3. Review.

PMID:
28124877
5.

Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.

Aguilar Peralta GR, Arévalo Gardoqui J, Llamas Macías FJ, Navarro Ceja VH, Mendoza Cisneros SA, Martínez Macías CG.

Int Angiol. 2007 Dec;26(4):378-84.

PMID:
18091707
6.

Patients' satisfaction with therapy methods of advanced chronic venous disease.

Chudek J, Mikosiński J, Kobielski A, Hering A, Aleksiejew-Kleszczyński T, Umiński J, Zubilewicz T, Kobusiewicz W, Iłżecki M, Wojtak A, Stec J, Urbanek T.

Int Angiol. 2016 Feb;35(1):98-107. Epub 2015 Sep 25.

PMID:
26406967
7.

Chronic venous disease: health status of a population and care impact on this health status through quality of life questionnaires.

Guex JJ, Myon E, Didier L, Nguyen Le C, Taieb C.

Int Angiol. 2005 Sep;24(3):258-64.

PMID:
16158036
8.

Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.

Vanscheidt W, Jost V, Wolna P, Lücker PW, Müller A, Theurer C, Patz B, Grützner KI.

Arzneimittelforschung. 2002;52(4):243-50.

PMID:
12040966
9.

Quality of life in chronic venous disease patients measured by short Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-14) in Serbia.

Radak DJ, Vlajinac HD, Marinković JM, Maksimović MŽ, Maksimović ZV.

J Vasc Surg. 2013 Oct;58(4):1006-13. doi: 10.1016/j.jvs.2011.08.003. Epub 2011 Nov 1.

10.
13.

Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced activation of endothelial cells.

Bouaziz N, Michiels C, Janssens D, Berna N, Eliaers F, Panconi E, Remacle J.

Int Angiol. 1999 Dec;18(4):306-12.

PMID:
10811519
14.

The influence of the CIVIQ dimensions on quality of life of patients with primary superficial venous incompetence.

Ortega-Santana F, Limiñana JM, Ruano F, Ortega-Centol A, Palomino-Martín A, Jiménez F.

Eur J Vasc Endovasc Surg. 2014 Oct;48(4):452-8. doi: 10.1016/j.ejvs.2014.07.006. Epub 2014 Aug 21.

15.

[Venous constriction by local administration of ruscus extract].

Berg D.

Fortschr Med. 1990 Aug 20;108(24):473-6. German.

PMID:
2227746
16.
17.

Correlations between ankle circumference, symptoms, and quality of life demonstrate the clinical relevance of minimal leg swelling reduction: results of a study in 1,036 Argentinean patients.

Guex JJ, Enrici E, Boussetta S, Avril L, Lis C, Taieb C.

Dermatol Surg. 2008 Dec;34(12):1666-75. doi: 10.1111/j.1524-4725.2008.34344.x. Epub 2008 Oct 13.

PMID:
19018827
18.

Venous leg ulcer in the context of chronic venous disease.

Lozano Sánchez FS, Marinel lo Roura J, Carrasco Carrasco E, González-Porras JR, Escudero Rodríguez JR, Sánchez Nevarez I, Díaz Sánchez S; Sociedades Españolas de Angiología y Cirugía Vascular (SEACV); Capítulo Español de Flebologia, the Médicos de Atención Primaria (SEMERGEN); Medicina Familiar y Comunitaria (SemFYC).

Phlebology. 2014 May;29(4):220-6. doi: 10.1177/0268355513480489. Epub 2013 May 6.

PMID:
23538963
19.

Comparison of disease-specific quality of life tools in patients with chronic venous disease.

Kuet ML, Lane TR, Anwar MA, Davies AH.

Phlebology. 2014 Dec;29(10):648-53. doi: 10.1177/0268355513501302. Epub 2013 Aug 20.

PMID:
23963729
20.

Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).

Allaert FA, Hugue C, Cazaubon M, Renaudin JM, Clavel T, Escourrou P.

Int Angiol. 2011 Jun;30(3):272-7.

PMID:
21617611

Supplemental Content

Support Center